Pesquisas alternativas:
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
developed teen » developed test (Expandir a Pesquisa), developed open (Expandir a Pesquisa), developed between (Expandir a Pesquisa)
fds developed » foods developed (Expandir a Pesquisa), has developed (Expandir a Pesquisa), films developed (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rates (Expandir a Pesquisa), level race (Expandir a Pesquisa)
drug disease » lung disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drugs fds » drugs fda (Expandir a Pesquisa), drugs ads (Expandir a Pesquisa), drugs frids (Expandir a Pesquisa)
disease levels » disease level (Expandir a Pesquisa), dismutase levels (Expandir a Pesquisa), decrease levels (Expandir a Pesquisa)
developed teen » developed test (Expandir a Pesquisa), developed open (Expandir a Pesquisa), developed between (Expandir a Pesquisa)
fds developed » foods developed (Expandir a Pesquisa), has developed (Expandir a Pesquisa), films developed (Expandir a Pesquisa)
level rather » levels rather (Expandir a Pesquisa), level rates (Expandir a Pesquisa), level race (Expandir a Pesquisa)
drug disease » lung disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
doses level » dose level (Expandir a Pesquisa), does level (Expandir a Pesquisa), dose levels (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drugs fds » drugs fda (Expandir a Pesquisa), drugs ads (Expandir a Pesquisa), drugs frids (Expandir a Pesquisa)
141
Por Cheruiyot, Agnes C., Auschwitz, Jennifer M., Lee, Patricia J., Yeda, Redemptah A., Okello, Charles O., Leed, Susan E., Talwar, Mayank, Murthy, Tushar, Gaona, Heather W., Hickman, Mark R., Akala, Hoseah M., Kamau, Edwin, Johnson, Jacob D.
Publicado no Antimicrob Agents Chemother (2016)
“... isolates with various low levels of parasitemia. To be advantageous, malaria drug sensitivity assays should...”Publicado no Antimicrob Agents Chemother (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
142
“... ALT levels were increased at 6 hours after dosing in hUGT1 mice and at 24 hours after dosing...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
143
Por Kermer, Pawel, Digicaylioglu, Murat H., Kaul, Marcus, Zapata, Juan M., Krajewska, Maryla, Stenner‐Liewen, Frank, Takayama, Shinichi, Krajewski, Stanistan, Lipton, Stuart A., Reed, John C.
Publicado no Brain Pathol (2006)
“... over‐expressing BAG1 in neurons. While brain development was essentially normal, cultured cortical...”Publicado no Brain Pathol (2006)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
144
Por Levine, Todd D., Bowser, Robert, Hank, Nicole C., Gately, Stephen, Stephan, Dietrich, Saperstein, David S., Van Keuren-Jensen, Kendall
Publicado em 2012
“... = .18). Over six months of therapy, CSF tau levels decreased in subjects randomized to active treatment...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
145
Por Todd D. Levine, Robert Bowser, Nicole C. Hank, Stephen Gately, Dietrich Stephan, David S. Saperstein, Kendall Van Keuren-Jensen
Publicado em 2012-01-01
“...). Over six months of therapy, CSF tau levels decreased in subjects randomized to active treatment...”Publicado em 2012-01-01
Obter o texto integral
Artigo
146
Por Shelke, Namdev B, Kadam, Rajendra, Tyagi, Puneet, Rao, Vidhya R, Kompella, Uday B.
Publicado em 2011
“... injection in New Zealand white rabbits. Drug levels in the microparticle dosed eyes at 3 months were 43.7...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
147
Por Wang, Liang
Publicado em 2010
“...-of-the-art MDCT depicts and quantifies hepatic disease over conventional CT for not only depicting lesion...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
148
Por Hori, Yukiko, Takeda, Shuko, Cho, Hansang, Wegmann, Susanne, Shoup, Timothy M., Takahashi, Kazue, Irimia, Daniel, Elmaleh, David R., Hyman, Bradley T., Hudry, Eloise
Publicado no J Biol Chem (2015)
“... disease. Here we demonstrate that cromolyn sodium (disodium cromoglycate), a Food and Drug Administration...”Publicado no J Biol Chem (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
149
Por Dumitriu, Alexandra, Pacheco, Chris D., Wilk, Jemma B., Strathearn, Katherine E., Latourelle, Jeanne C., Goldwurm, Stefano, Pezzoli, Gianni, Rochet, Jean-Christophe, Lindquist, Susan, Myers, Richard H.
Publicado em 2011
“.../threonine kinase, belongs to a family of proteins commonly targeted for drug development. This, combined...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
150
Por Pedersen, Lise, Szecsi, Pal Bela, Johansen, Per Birger, Bjerrum, Poul Jannik
Publicado no Biologics (2020)
“... different tumor necrosis factor inhibitors, drug levels and antidrug antibodies were measured over a period...”Publicado no Biologics (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
151
152
Por Rahman, Raziur, Dhruba, Saugato Rahman, Ghosh, Souparno, Pal, Ranadip
Publicado no Sci Rep (2019)
“... drug sensitivity profile which can be used to design the optimal dose for a patient. In this article...”Publicado no Sci Rep (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
153
Por Ansbro, Éimhín, Garry, Sylvia, Karir, Veena, Reddy, Amulya, Jobanputra, Kiran, Fardous, Taissir, Sadique, Zia
Publicado no Health Policy Plan (2020)
“... sans Frontières (MSF) developed a primary-level NCD programme, serving Syrian refugees and the host...”Publicado no Health Policy Plan (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
154
Por Mathur, Shrey, Jackson, Charlotte, Urus, Heather, Ziarko, Isabelle, Goodbun, Matt, Hsia, Yingfen, Ellis, Sally, Sharland, Mike
Publicado no Bull World Health Organ (2020)
“... identified stem from different clinical disease patterns, varying levels of antibiotic resistance or drug...”Publicado no Bull World Health Organ (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
155
Por de Cates, Angharad N, Farr, Matthew RB, Wright, Nicola, Jarvis, Morag C, Rees, Karen, Ebrahim, Shah, Huffman, Mark D
Publicado em 2014
“.... Fixed-dose combination therapy improved adherence to a multi-drug strategy by 33% (26% to 41%) compared...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
156
157
“... prescribing rates for five major coronary heart disease (CHD) drug groups. Design: Cross sectional secondary...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
158
“... individuals on HAART in British Columbia, Canada, 1996–2011. METHODS: We used population-level data on disease...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
159
Por Kinsey, Tracy L., Stürmer, Til, Poole, Charles, Rothman, Kenneth J., Glynn, Robert J.
Publicado no Pharmacoepidemiol Drug Saf (2018)
“... coronary heart disease, and before and after publication of National Cholesterol Education Program Adult...”Publicado no Pharmacoepidemiol Drug Saf (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
160
“... in the mother’s hormone level and the effect of drug therapy on both the mother and her fetus. Thus...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo